BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2861207)

  • 21. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
    Ahmed M; Cramer SD; Lyles DS
    Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response.
    Ostertag D; Hoblitzell-Ostertag TM; Perrault J
    J Virol; 2007 Jan; 81(2):503-13. PubMed ID: 17065213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
    Maheshwari RK; Jay FT; Friedman RM
    Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of Sindbis virus-induced intrinsic interference with vesicular stomatitis virus replication.
    Hunt JM; Marcus PI
    J Virol; 1974 Jul; 14(1):99-109. PubMed ID: 4365326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pH independence of mammalian retrovirus infection.
    McClure MO; Sommerfelt MA; Marsh M; Weiss RA
    J Gen Virol; 1990 Apr; 71 ( Pt 4)():767-73. PubMed ID: 2157795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons.
    Belkowski LS; Sen GC
    J Virol; 1987 Mar; 61(3):653-60. PubMed ID: 3027394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3,11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin.
    Barquero AA; Alché LE; Coto CE
    J Gen Virol; 2004 Feb; 85(Pt 2):483-493. PubMed ID: 14769906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of vesicular stomatitis virus multiplication in Vero cells by 2-deoxy-D-glucose.
    Sabina LR; Telasco CE
    Acta Virol; 1979 May; 23(3):210-20. PubMed ID: 41433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Entry of poliovirus type 1 and Mouse Elberfeld (ME) virus into HEp-2 cells: receptor-mediated endocytosis and endosomal or lysosomal uncoating.
    Zeichhardt H; Wetz K; Willingmann P; Habermehl KO
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():483-92. PubMed ID: 2857762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissection of the Golgi complex. II. Density separation of specific Golgi functions in virally infected cells treated with monensin.
    Quinn P; Griffiths G; Warren G
    J Cell Biol; 1983 Mar; 96(3):851-6. PubMed ID: 6403555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins.
    Kääriäinen L; Hashimoto K; Saraste J; Virtanen I; Penttinen K
    J Cell Biol; 1980 Dec; 87(3 Pt 1):783-91. PubMed ID: 6257729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
    Doll SC; Johnson TC
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the non-permissive infection of rabbit cornea cells by vesicular stomatitis virus.
    Hamilton DH; Moyer RW; Moyer SA
    J Gen Virol; 1980 Aug; 49(2):273-87. PubMed ID: 6255068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cell membrane composition in receptor-mediated internalization of vesicular stomatitis virus in human HEp-2 cells.
    Pottathil R; Gutierrez PL; Davis LH; Chandrabose KA
    J Biol Chem; 1985 May; 260(9):5265-70. PubMed ID: 2985585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound.
    Müller-Decker K; Amtmann E; Sauer G
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3045-56. PubMed ID: 2447222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. the influence of the host cell on the inhibition of virus protein synthesis in cells double infected with vesicular stomatitis virus and mengovirus.
    Otto MJ; Lucas-Lenard J
    J Gen Virol; 1980 Oct; 50(2):293-307. PubMed ID: 6257824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.
    Pattnaik AK; Wertz GW
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1379-83. PubMed ID: 1847519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.